Our research strengths include cancer genomics, DNA damage, RNA biology, and drug development. We are developing expertise in drug delivery, with a focus on nanotechnology-driven delivery of small RNA mimics and inhibitors.
Translating today's discoveries in childhood cancer research into tomorrow's treatments.
Greehey Children’s Cancer Research Institute is only one of two institutes in the United States dedicated solely to pediatric cancer research. Its 18 laboratories focus their strengths in cancer genomics, DNA repair, RNA biology, and drug development on finding new and less toxic treatments for childhood cancers.
Top stories
News
Events
-
Greehey CCRI Fall Seminar Series: Poulikos I. Poulikakos, PhD, Mount Sinai (virtual)
Presentation Title: Next-Generation Strategies Targeting Oncogenic Signaling for Cancer Therapy -
Greehey CCRI Seminar Series: Gang Fang, PhD – Mount Sinai (virtual)
Presentation Title: "Mapping Multiple Forms of DNA Methylation in Pathogens, Microbiome, and Humans." -
Greehey CCRI Seminar Series: Ioannis Aifantis, PhD – NYU (virtual)
Presentation Title: “RNA binding Proteins and the Regulation of Leukemia Progression and Drug Response”